MG
GILD icon

Markel Group’s Gilead Sciences GILD Stock Holding History

Markel Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-33,000
Closed -$2.49M – 141
2018
Q1 		$2.49M Hold
33,000
– – 0.05% 115
2017
Q4 		$2.36M Hold
33,000
– – 0.04% 119
2017
Q3 		$2.67M Hold
33,000
– – 0.05% 117
2017
Q2 		$2.34M Buy
33,000
+6,000
+22% +$399K 0.05% 121
2017
Q1 		$1.83M Buy
27,000
+13,000
+93% +$914K 0.04% 117
2016
Q4 		$1M Buy
+14,000
New +$1.04M 0.02% 120

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Markel Group's GILD Position: Q2 2018 in Review

Markel Group sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 33,000 shares — an estimated $2.49M sold.

Markel Group first reported a position in GILD in Q4 2016 and held it in 6 quarters. The position peaked at $2.67M in Q3 2017. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Markel Group reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Markel Group sold 33,000 Gilead Sciences shares in Q2 2018, an estimated $2.49M.
  • Markel Group first reported a position in Gilead Sciences in Q4 2016 and held it in 6 quarters.
  • Markel Group's Gilead Sciences position peaked at $2.67M in Q3 2017.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Markel Group's 13F filing for Q2 2018, filed 3 Aug 2018.